INTRODUCTION AND AIMS: To study rates of 3-month retention in a drug treatment therapeutic community and the characteristics of residents who remain in treatment. DESIGN AND METHODS: A total of 200 consecutive admissions to a therapeutic community in Christchurch, New Zealand received a structured interview and questionnaires and were prospectively followed for 3 months. Assessments included the Modified Mini-International Neuropsychiatric Interview (MINI), Hopkins Symptom Checklist (SCL-90), Temperament Character Inventory (TCI) and Short Form Health Survey (SF-36). RESULTS: A total of 107 out of 187 residents remained in the program for at least 3 months. These residents had a better baseline mental health score (SF-36), higher lifetime depression, higher current sedative/hypnotic dependence and less lifetime stimulant dependence. The differences were modest and predicted around 18% of the variance in outcome. DISCUSSION AND CONCLUSIONS: The retention rate is consistent with other studies. Few variables predict those who discontinue treatment supporting a non-discriminatory approach to new residents by clinicians.
INTRODUCTION AND AIMS: To study rates of 3-month retention in a drug treatment therapeutic community and the characteristics of residents who remain in treatment. DESIGN AND METHODS: A total of 200 consecutive admissions to a therapeutic community in Christchurch, New Zealand received a structured interview and questionnaires and were prospectively followed for 3 months. Assessments included the Modified Mini-International Neuropsychiatric Interview (MINI), Hopkins Symptom Checklist (SCL-90), Temperament Character Inventory (TCI) and Short Form Health Survey (SF-36). RESULTS: A total of 107 out of 187 residents remained in the program for at least 3 months. These residents had a better baseline mental health score (SF-36), higher lifetime depression, higher current sedative/hypnotic dependence and less lifetime stimulant dependence. The differences were modest and predicted around 18% of the variance in outcome. DISCUSSION AND CONCLUSIONS: The retention rate is consistent with other studies. Few variables predict those who discontinue treatment supporting a non-discriminatory approach to new residents by clinicians.
Authors: F Vigna-Taglianti; F Mathis; R Diecidue; E Trogu; U Kirchmayer; J Ghibaudi; G Piras; A Camposeragna; A Saponaro; L Amato; M Davoli; F Faggiano; P P Pani Journal: Community Ment Health J Date: 2017-02-08
Authors: Iman Parhami; Margarit Davtian; Michael Collard; Jean Lopez; Timothy W Fong Journal: J Behav Health Serv Res Date: 2014-07 Impact factor: 1.505
Authors: Marie-Josée Fleury; Guy Grenier; Jean-Marie Bamvita; Michel Perreault; Jean Caron Journal: Can J Psychiatry Date: 2014-04 Impact factor: 4.356
Authors: R Kathryn McHugh; Heather W Murray; Bridget A Hearon; Elizabeth M Pratt; Mark H Pollack; Steven A Safren; Michael W Otto Journal: Am J Addict Date: 2013-01